TY - JOUR
T1 - Chronic methamphetamine psychosis after long-term abstinence in Japanese incarcerated patients
AU - Akiyama, Kazufumi
AU - Saito, Atsushi
AU - Shimoda, Kazutaka
N1 - Copyright:
Copyright 2011 Elsevier B.V., All rights reserved.
PY - 2011/5
Y1 - 2011/5
N2 - Eighty female incarcerated subjects who maintained a long-term methamphetamine (METH) abstinence, but manifested psychosis, were examined for correlations among symptom severity premorbid diathesis, recurrence, and adverse effects of pharmacotherapy. Baseline symptoms were assessed with a 24-item version of the Brief Psychiatric Rating Scale (BPRS) prior to, and 2 weeks after, the commencement of pharmacotherapy. Fifty-four subjects who had abused volatile solvents in their teenage years commenced METH abuse at a significantly lower age than the rest of the subjects (18.4 vs. 22.5 years old, p <.001). Twenty-nine patients who had attempted suicide in their lives suffered from premorbid psychiatric disorders significantly more often than those who had never attempted suicide (odds ratio = 8.6, 95% confidence interval [CI]= 2.6-27.8, p <.001). Twenty subjects who manifested spontaneous recurrence had a significantly longer abstinence period (17.5 vs. 12.1 months, p =.049), but suffered from premorbid psychiatric disorders significantly less often (odds ratio =.12, 95% CI =.02-.99, p =.031) than those who manifested nonrecurrent-protracted psychosis. Subjects who eventually suffered from extrapyramidal symptoms (EPS) following pharmacotherapy had higher total BPRS scores at the baseline assessment. The present study provides evidence that a subpopulation of METH abusers suffered from chronic METH psychosis in long-term abstinence, and also highlights the involvement of affective symptoms in its severity.
AB - Eighty female incarcerated subjects who maintained a long-term methamphetamine (METH) abstinence, but manifested psychosis, were examined for correlations among symptom severity premorbid diathesis, recurrence, and adverse effects of pharmacotherapy. Baseline symptoms were assessed with a 24-item version of the Brief Psychiatric Rating Scale (BPRS) prior to, and 2 weeks after, the commencement of pharmacotherapy. Fifty-four subjects who had abused volatile solvents in their teenage years commenced METH abuse at a significantly lower age than the rest of the subjects (18.4 vs. 22.5 years old, p <.001). Twenty-nine patients who had attempted suicide in their lives suffered from premorbid psychiatric disorders significantly more often than those who had never attempted suicide (odds ratio = 8.6, 95% confidence interval [CI]= 2.6-27.8, p <.001). Twenty subjects who manifested spontaneous recurrence had a significantly longer abstinence period (17.5 vs. 12.1 months, p =.049), but suffered from premorbid psychiatric disorders significantly less often (odds ratio =.12, 95% CI =.02-.99, p =.031) than those who manifested nonrecurrent-protracted psychosis. Subjects who eventually suffered from extrapyramidal symptoms (EPS) following pharmacotherapy had higher total BPRS scores at the baseline assessment. The present study provides evidence that a subpopulation of METH abusers suffered from chronic METH psychosis in long-term abstinence, and also highlights the involvement of affective symptoms in its severity.
UR - http://www.scopus.com/inward/record.url?scp=79953894399&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79953894399&partnerID=8YFLogxK
U2 - 10.1111/j.1521-0391.2011.00124.x
DO - 10.1111/j.1521-0391.2011.00124.x
M3 - Article
C2 - 21477052
AN - SCOPUS:79953894399
SN - 1055-0496
VL - 20
SP - 240
EP - 249
JO - American Journal on Addictions
JF - American Journal on Addictions
IS - 3
ER -